Dickran Kazandjian1,2, Yutao Gong1, Gideon M Blumenthal1. 1. Oncology Center of Excellence and Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland. 2. Multiple Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Authors: Ashley M Hopkins; Ganessan Kichenadasse; Ahmad Y Abuhelwa; Ross A McKinnon; Andrew Rowland; Michael J Sorich Journal: Cancers (Basel) Date: 2021-03-09 Impact factor: 6.639